Tirzepatide, used in Zepbound and Mounjaro, targets both the GLP-1 and the GIP receptor agonist, while semaglutide, found in Wegovy and Ozempic, mimics only the GLP-1 receptor agonist, a type of hormone in the body that impacts everything from the brain to muscle to the pancreas, stomach and liver
Low blood sugar: In patients with type 2 diabetes, semaglutide can cause low blood sugar levels (hypoglycemia) when used in combination with other diabetes medications
Whole wheat bread, quinoa, and brown rice are just a few examples of healthier options
GLP-1 medications are intriguing from a cancer research perspective because they werent designed for cancer therapy, but they do affect many different targets and pathways associated with cancer development, so were eager to study them in this context, Dr